Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor α (RARα) and PLZF-RARα fusion proteins on retinoic acid signalling

Molecular and Cellular Biology

Volumn 17, Issue 8, 1997, Pages 4859-4869

  Ruthardt, Martin ^b   Testa, Ugo ^c   Nervi, Clara ^d   Ferrucci, Pier Francesco ^a   Grignani, Francesco ^b   Puccetti, Elena ^a   Grignani, Fausto ^b   Peschle, Cesare ^c,e   Pelicci, Pier Giuseppe ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; NUCLEAR PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RETINOIC ACID; RETINOIC ACID RECEPTOR; VIRUS PROTEIN; ZINC FINGER PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BLAST CELL; CANCER REGRESSION; CELL DIFFERENTIATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

ANIMALIA; POXVIRIDAE;

EID: 0030789181     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.8.4859     Document Type: Article

References (56)

1. Bardwell, V. J., and R. Treisman. 1994. The POZ domain: a conserved protein-protein interaction motif. Genes Dev. 8:1664-1677.
2. Benedetti, L., F. Grignani, B. M. Scicchitano. A. M. Jetten, D. Diverio, F. Lo Coco, C. Gambacorti-Passerini, S. Adamo, A. A. Levin, P. G. Pelicci, and C. Nervi. 1996. Retinoid-induced differentiation of acute promyelocytic leukaemia involves PML/RARα-mediated increase of type II transglutaminase. Blood 87:1939-1950.
3. 2a.Brown, D., S. Kogan, E. Lagasse, I. Weissman, M. Alcalay, P. G. Pelicci, S. Atwater, and M. J. Bishop. 1997. A PML/RARα transgene initiates murine acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94:2551-2556.
4. Chambon, P. 1994. The retinoid signalling pathway: molecular and genetic analyses. Semin. Cell Biol. 5:115-125.
5. Chen, D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
6. Chen, Z., N. J. Brand, A. Chen, S. J. Chen, J. H. Tong, Z. Y. Wang, S. Waxman, and A. Zelent. 1993. Fusion between a novel Krüppel-like zinc finger gene and retinoic acid receptor-α locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 12: 1161-1167.
7. Chen, Z., F. Guidez, P. Rousselot, A. Agadir, S. J. Chen, Z. Y. Wang, L. Degos, A. Zelent, S. Waxman, and C. Chomienne. 1994. PLZF/RARα fusion proteins generated from the variant t(11;17) (q23;q21) translocation in acute promyelocytic leukaemia inhibit ligand-dependent transactivation of wildtype retinoic acid receptors. Proc. Natl. Acad. Sci. USA 91:1178-1182.
8. Collins, S. J. 1987. The HL-60 promyelocytic leukaemia cell line: proliferation, differentiation, and cellular oncogene expression Blood 70:1233-1244.
9. Collins, S. J., K. Robertson, and L. Mueller. 1990. Retinoic-acid induced granulocytic differentiation of HL-60 cells is mediated directly through the retinoic acid receptor (RARα). Mol. Cell. Biol. 10:2154.
10. Degos, L., C. Chomienne, M. T. Daniel, R. Berger, H. Dombret, P. Fenaux, and S. Castaigne. 1990. Treatment of first relapse in acute promyelocytic leukemia with all-trans retinoic acid. Lancet 336:1440-1443.
11. de Thé, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RARα. Cell 66:675-684.
12. Dong, S., J. Zhu, A. Reid, P. Strutt, F. Guidez, H. J. Zhong, Z. Y. Wang, J. Licht, S. Waxman, C. Chomienne, Z. Chen, A. Zelent, and S. J. Chen. 1996. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukaemia zinc finger-retinoic acid receptor-a fusion protein. Proc. Natl. Acad. Sci. USA 93:3624-3629.
13. Dyck, J. A., G. G. Maul, W. H. Miller, Jr., J. D. Chen, A. Kakizuka, and R. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333-343.
14. 12a.Ferrucci, P. F., F. Grignani, M. Fagioli, F. Griynani, I. Nicoletti, and P. G. Pelicci. Cell death induction by the acute promyelocytic leukemia specific PML/RARα fusion protein. Submitted for publication.
15. Giudez, F., W. Huang, J. T. Tong, C. Dubois, N. Balitrand, J. Michaux, P. Martiat, L. Degos, S. Waxman, and C. Chomienne. 1994. Poor response to all-trans retinoic acid in a t(11;17) PLZF/RARα AML3 patient. Leukaemia 8:312-314.
16. Grignani, F., P. F. Ferrucci, U. Testa, G. Talamo, M. Fagioli, M. Alcalay, A. Mencarelli, F. Grignani, C. Peschle, I. Nicoletti, and P. G. Pelicci. 1993. The acute promyelocytic leukaemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423-431.
17. Grignani, F., M. Fagioli, M. Alcalay, L. Longo, P. P. Pandolfi, E. Donti, A. Biondi, F. Lo Coco, F. Grignani, and P. G. Pelicci. 1994. Acute promyelocytic leukaemia: from genetics to treatment. Blood 83:10-25.
18. Grignani, F., U. Testa, M. Fagioli, T. Barberi, R. Masciulli, G. Mariani, C. Peschle, and P. G. Pelicci. 1995. Promyelocytic leukaemia-specific PML-retinoic acid α receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells. Cancer Res. 85:440-443.
19. Grignani, F., U. Testa, D. Rogaia, P. F. Ferrucci, P. Samoggia, A. Pinto, D. Aldinucci, V. Gelmetti, M. Fagioli, M. Alcalay, J. Seeler, F. Grignani, I. Nicoletti, C. Peschle, and P. G. Pelicci. 1996. Effects on differentiation by the promyelocytic leukaemia PML/RARα protein depend on the fusion of the PML protein-dimerization and RARα DNA binding domains. EMBO J. 15:4949-4958.
20. Grisolano, J. L., R. L. Wesselschmidt, P. G. Pelicci, and T. J. Ley. 1996. Early myeloid expression of PML/RARα fusion gene associated with acute promyelocytic leukaemia (APL) in transgenic mice alters myeioid development. Blood 86(Suppl. 1):430a.
21. Horlein, A. J., A. M. Näär, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. K. Glass, and M. G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-403.
22. Huang, M., Y. Yu-Chen, C. Shu-Rong, J. Chai, Z. Lin, J. Long, and Z. Wang. 1988. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567-571.
23. Jetten, A. M., J. F. Grippo, and C. Nervi. 1990. Isolation and binding characteristics of nuclear retinoic acid receptors. Methods Enzymol. 189: 248-255.
24. Kakizuka, A., W. H. Miller, Jr., K. Umesono, R. P. Warrel, Jr., S. R. Frankel, V. V. V. S. Murty, E. Dmitrovsky, and R. M. Evans. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663-674.
25. Kamei, Y., L. Xu, T. Heizel, J. Torchia, R. Kurokawa, B. Gloss, S. C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
26. Kastner, P., A. Perez, Y. Lutz, C. Rochette-Egly, M. P. Gaub, B. Durand, M. Lanotte, R. Berger, and P. Chambon. 1992. Structure, localization and transcriptional properties of two classes of retinoic acid receptor a fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11:629-642.
27. Kastner, P., M. Leid, and P. Chambon. 1994. The role of nuclear retinoic acid receptors in the regulation of gene expression, p. 189-238. In R. Blomhoff (ed.), Vitamin A in health and disease. Marcel Dekker, New York, N.Y.
28. 3 signalling. Nature 355:446-449.
29. Koken, M. H. M., F. Puvio-Dutilleul, M. C. Guillemin, A. Viron, G. Cruz-Linares. N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, C. Chomienne, L. Degos, E. Puvion, and H. de Thè. 1994. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13:1073-1083.
30. Kurokawa, R., M. Soderstrom, A. Hörlein, S. Halachmi, M. Brown, M. G. Rosenfeld, and C. K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454.
31. Le Dourain, B., C. Zechel, J. M. Garnier, Y. Lutz, L. Tora, B. Pierrat, D. Heery, H. Gronemeyer, P. Chambon, and R. Losson. 1995. The N-terminal part of TIF-1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14:2020-2033.
32. Lee, J. W., F. Ryan, J. C. Swaffield, S. A. Johnston, and D. D. Moore. 1995. Interaction of thyroid hormone receptor with a conserved transcriptional mediator. Nature 374:91-94.
33. Licht, J. D., C. Chomienne, A. Goy, A. Chen, A. A. Scott, D. R. Head, J. L. Michaux, Y. Wu, A. De Blasio, W. H. Miller, Jr., A. D. Zelenetz, C. L. Willman, Z. Chen, S. J. Chen, A. Zelent, E. Macintyre, A. Veil, J. Cortes, H. Kantarjian, and S. Waxman. 1995. Clinical and molecular characterisation of a rare syndrome of acute promyelocytic leukaemia associated with translocation (11;17). Blood 85:1083-1094.
34. Licht, J. D., R. Shaknovich, M. A. English, A. Melnick, J.-Y. Li, J. C. Reddy, S. Dong, S. J. Chen, A. Zelent, and S. Waxman. 1996. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-a chimera generated in t(11;17)-associated acute promyelocytic leukaemia. Oncogene 12:323-336.
35. LoCoco, F., G. Avvisati, D. Diverio, M. C. Petti, M. Alcalay, P. P. Pandolfi, A. Biondi, A. Rambaldi, M. L. Moleti, F. Mandelli, and P. G. Pelicci. 1991. Molecular evaluation of response to all-trans retinoic acid therapy in patients with acute promyelocytic leukaemia. Blood 77:1657-1659.
36. Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-850.
37. Mendelsohn, C., E. Ruberte, M. LeMeur, G. Morris-Kay, and P. Chambon. 1991. Developmental analysis of the retinoic acid-inducible RARβ2 promoter in transgenic animals. Development 113:723-734.
38. Minucci, S., and K. Ozato. 1996. Retinoid receptors in transcriptional regulation. Curr. Opin. Genet. Dev. 6:567-574.
39. Mitelman, F. 1988. Catalogue of chromosome aberrations in cancer, 3rd ed. Alan R. Liss, Inc., New York, N.Y.
40. Nagpal, S., M. Saunders, P. Kastner, B. Durand, H. Nakshatri, and P. Chambon. 1992. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70:1007-1019.
41. Nervi, C., C. E. Poindexter, F. Grignani, P. P. Pandolfi, F. Lo Coco, G. Avvisati, P. G. Pelicci, and A. M. Jetten. 1992. Characterisation of the PML/RARα chimeric product of the acute promyelocytic leukaemia-specific t(15;17) translocation. Cancer Res. 52:3687-3692.
42. Olsson, I. L., and R. T. Breitman. 1982. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3′:5′-monophosphate-inducing agents. Cancer Res. 42:3924-3927.
43. Onate, S. A., S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1995. Sequence and characterisation of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
44. Pandolfi, P. P., F. Grignani, M. Alcalay, A. Mencarelli, A. Biondi, F. Lo Coco, F. Grignani, and P. G. Pelicci. 1991. Structure and origin of the acute promyelocytic leukemia myl/RARα cDNA and characterization of its retinold-binding and transactivation properties. Oncogene 6:1285-1292.
45. Pandolfi, P. P., M. Alcalay, M. Fagioli, D. Zangrilli, A. Mencarelli, D. Diverio, A. Biondi, F. Lo Coco, A. Rambaldi, F. Grignani, C. Rochette-Egly, M. P. Gaube, P. Chambon, and P. G. Pelicci. 1992. Genomic variability and alternative splicing generate multiple PML-RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukaemia. EMBO J. 11:1397-1407.
46. Perez, A., P. Kastner, S. Sethi, Y. Lutz, C. Reibel, and P. Chambon. 1993. PMLRARα homodimers: distinct DNA binding properties and heterodimeric interaction with RXR. EMBO J. 12:3171-3182.
47. Robertson, K. A., B. Emami. and S. J. Collins. 1992. Retinoic acid-resistant HL-60R cells harbour a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80:1885-1889.
48. Sambrook, J., E. F, Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
49. Smith, N. C., H. Nakshatri, P. Leroy, J. Rees, and P. Chambon. 1991. A reinoic acid response element is present in the mouse cellular retinol binding protein I (mCRABP I) promoter EMBO J. 10:2223-2230.
50. Testa, U., F. Grignani, T. Barberi, M. Fagioli, R. Masciulli, P. F. Ferrucci, D. Seripa, A. Camagna, M. Alcalay, P. G. Pelicci, and C. Peschle. 1994. PML/RARα+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3. Cancer Res. 54:4508-4515.
51. Vom Baur, E., C. Zechel, D. Heery, M. J. S. Heine, J. M. Garnier, V. Vivat, B. Le Dourain, H. Gronemeyer, P. Chambon, and R. Losson. 1996. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15:110-124.
52. Warrel, R. P., Jr., S. R. Frankel, W. H. Miller, D. A. Scheinberg, L. M. Itri, W. N. Hittelman, R. Vyas, M. Andreeff, A. Tafuri, A. Jakubowski, J. Gabrilove, M. S. Gordon, and E. Dmitrovsky. 1991. Differentiation therapy of acute promyelocytic leukaemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 324:1358-1393.
53. Warrel, R. P., Jr., H. de Thé, Z. Y. Wang, and L. Degos. 1993. Acute promyelocytic leukemia. N. Engl. J. Med. 329:177-189.
54. Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carcalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear localisation of PML-RARα in acute promyelocytic leukaemia cells. Cell 76:345-358.
55. Yu, V. C., C. Delsert, B. Andersen, J. M. Holloway, O. V. Devary, A. M. Naar, S. Y. Kim, J. M. Boutin, C. K. Glass, and M. G. Rosenfeld. 1991. RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266.
56. Zhang, X. K., B. Hoffmann, P. B. V. Tran, G. Graupner, and M. Pfahl. 1992. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355:441-446.